RIPK2 and inflammatory breast carcinoma: Previous studies have shown that RIPK2 promotes the development of metastatic tumor tissues 6 and inflammatory breast cancer (IBC) 43, while the suppression of RIPK2 can hinder the migration of BC cells and reduce the occurrence of extrapulmonary metastasis 48.